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In regions of high rates of malaria transmission, mosquitoes repeatedly transmit liver-tropic Plasmodium sporozoites to individuals who already have blood-stage parasitemia 1 . This manifests itself in semi-immune children (who have been exposed since birth to Plasmodium infection and as such show low levels of peripheral parasitemia but can still be infected) older than 5 years of age by concurrent carriage of different parasite genotypes at low asymptomatic parasitemias 2 . Superinfection presents an increased risk of hyperparasitemia and death in less immune individuals but counterintuitively is not frequently observed in the young 3, 4 . Here we show in a mouse model that ongoing blood-stage infections, above a minimum threshold, impair the growth of subsequently inoculated sporozoites such that they become growth arrested in liver hepatocytes and fail to develop into blood-stage parasites. Inhibition of the liver-stage infection is mediated by the host iron regulatory hormone hepcidin 5 , whose synthesis we found to be stimulated by blood-stage parasites in a density-dependent manner. We mathematically modeled this phenomenon and show how density-dependent protection against liver-stage malaria can shape the epidemiological patterns of age-related risk and the complexity of malaria infections seen in young children. The interaction between these two Plasmodium stages and host iron metabolism has relevance for the global efforts to reduce malaria transmission and for evaluation of iron supplementation programs in malaria-endemic regions.
A bite from a Plasmodium-infected mosquito transmits sporozoites that infect hepatocytes, producing thousands of merozoites 6 that then infect red blood cells (RBCs) and cause malaria 7 . In areas where malaria is endemic, individuals can be exposed to several hundred bites from infected mosquitoes per year 1 , conferring a risk of superinfection.
In infants yet to acquire immunity and whose passively transferred maternal immunity has waned, individual infections result in potentially life-threatening episodes of disease 3 . Superinfections would be expected to elevate this risk (as different parasites may multiply independently, causing lethal parasitemias) but only if the sporozoites of a superinfection progress as they normally do through the liver stage in individuals that already have ongoing blood parasitemia.
To address this question, we used a mouse model of malaria where luciferase-and GFP-tagged parasites enable distinction between the original infection and the superinfection. We infected mice via mosquito bite with Plasmodium berghei parasites, and, after detecting parasites in the bloodstream (peripheral blood parasitemia (percentage of infected RBCs (iRBCs)) 0.99 ± 0.03%), we challenged the same mice by mosquito bite with luciferase-expressing P. berghei. Light emission correlates with P. berghei liver load 8 . Liver-stage infection was markedly inhibited in mice with ongoing blood-stage parasitemia (Fig. 1a) . The observed reduction in secondary Plasmodium liver infection depended on the ongoing blood-stage infection, as mice first infected with blood-stage parasites via blood transfusion and later challenged via mosquito bite with luciferase-expressing P. berghei showed a similar impairment in liver infection (Fig. 1b) . Most notably, luciferase-labeled parasites never reached detectable levels in the blood (Fig. 1c) . We confirmed a potent and significant reduction in P. berghei liver load in mice with an ongoing blood-stage infection and challenged with sporozoites constitutively expressing GFP (Fig. 1d) ; we used quantitative RT-PCR (qRT-PCR) of GFP mRNA as readout, as GFP expression correlates with P. berghei liver load (Supplementary Fig. 1 ). Again, we never detected GFPexpressing parasites in blood (Fig. 1e) . This effect was neither species nor strain specific, as mice carrying blood-stage infections with P. berghei NK65, P. berghei ANKA, Plasmodium chabaudi chabaudi AS or Plasmodium yoelii 17X parasites and challenged with GFPexpressing P. berghei ANKA sporozoites showed a marked reduction in liver-stage infection (P < 0.01; Fig. 1d ). Likewise, P. berghei NK65 blood-stage infection significantly inhibited liver-stage infection by GFP-expressing P. yoelii 17X sporozoites (P < 0.05; Fig. 1f) .
We consistently observed the decrease in liver parasite load from day 3 to day 14 of a blood-stage malaria infection started with 1 × 10 6 iRBCs, when parasitemia remained above 1% (1.24 ± 0.24-15.53 ± 3.80%; P < 0.05; Fig. 1g) . Additionally, when we initiated blood-stage parasitemia with increasing numbers of transferred P. berghei NK65 iRBCs (1 × 10 3 -1 × 10 7 iRBCs) and re-infected the mice with GFP-expressing P. berghei ANKA sporozoites on day 3, we observed significant impairment in liver-stage infection at parasitemias exceeding 0.15% (0.16 ± 0.07-3.61 ± 0.63%; P < 0.01) (induced after inoculation with 1 × 10 5 iRBCs) (P < 0.05; Fig. 1h ). Conversely, if we treated ongoing blood-stage infection with the antimalarial drug chloroquine or allowed the infection to naturally clear from circulation (as during P. c. chabaudi AS infections), inhibition of liver-stage development was abrogated (Fig. 1i,j) . These data suggest that the observed decrease in liver parasites only occurs above a certain critical threshold of blood parasite density.
We next investigated the mechanism of inhibition of Plasmodium liver-stage infection by ongoing blood-stage infection. Microscopic examination of liver sections from control and re-infected mice from three independent experiments clearly revealed that both the number and size of exoerythrocytic forms (EEFs) decreased in the presence of blood-stage parasites when measured 40-48 h after sporozoite inoculation (Fig. 2a-d and Supplementary Fig. 1 ). Together, these reductions account for the overall impairment to liver-stage development and mimic the observed reduction in infection liver load quantified by qRT-PCR in the same livers (Fig. 2d) . No EEFs were detectable 72 h after sporozoite infection in mice with a blood-stage infection (Supplementary Fig. 1) .
Altogether, these data indicate that inhibition of Plasmodium liver infection by an ongoing malaria blood-stage infection is independent of the Plasmodium species, is transient and results in small EEFs that fail to generate detectable blood-stage infections. The data are also consistent with a critical density threshold of blood-stage parasites inhibiting the development of the liver stage, resembling a quorum-sensing mechanism akin to those used by bacteria 9 , by which the blood-stage parasites are able to protect their niche from the threat of superinfection. We ruled out the possibility that a soluble factor secreted by blood-stage parasites was directly responsible for mediating inhibition, as infection of both mouse primary hepatocytes and human hepatoma cells by P. berghei sporozoites was unaffected by co-culturing with iRBCs ( Fig. 2e and Supplementary Fig. 2) .
We next examined differences in host liver transcription between naive mice, sporozoite-infected mice, mice carrying a P. berghei NK65 blood-stage infection alone or after secondary P. berghei ANKA sporozoite infection by genome-wide microarray analysis. Immune-related genes were upregulated in both mice with blood-stage infection alone and in mice after secondary sporozoite infection, and genes associated with a defense response, including those encoding several Toll-like receptors, chemokines, complement components and interferon (IFN) regulatory factors were upregulated in the latter (Fig. 2f,  Supplementary Fig. 3 and Supplementary Table 1), suggesting that a blood-stage parasite-initiated immune response might account for impaired liver-stage development. However, in splenectomized mice, mice genetically deficient for T and B cells, natural killer cells, γδ T cells, IFN-γ, nitric oxide synthase, interleukin-10, and myeloid differentiation factor-88 signaling, the C5a-complement factor or mast cells or in mice depleted of tumor necrosis factor-α or IL-6, we showed that the impairment of P. berghei liver infection in the presence of blood-stage parasitemia is independent of these factors (Fig. 2g-i and Supplementary Fig. 3 ). Lack of any of these independent components, or the administration of a general anti-inflammatory molecule (N-acetyl-cysteine) ( Supplementary  Fig. 3 ), did not even partially rescue the observed impairment of liverstage infection. Moreover, luciferase-labeled parasites never reached detectable levels in the blood of immunosuppressed (severe combined immunodeficient) re-infected mice. These data do not support a role of adaptive immunity or aspects of innate immunity in the phenotype observed (Supplementary Fig. 3) .
Plasmodium blood-stage parasites increase apoptosis in hepatocytes 10 , and microarray data showed a robust proapoptotic stimulus in the livers of mice with an ongoing blood-stage infection (Supplementary Table 1 ). However, although we observed a significantly reduced level of apoptosis in P. berghei NK65 bloodstage-infected, caspase-3-deficient mice (P < 0.01, Supplementary  Fig. 4 ), blood-stage infection in these mice still impaired a secondary P. berghei ANKA liver infection (P < 0.05; Fig. 2j) . Thus, hepatocyte apoptosis does not explain the observed protection.
The reduction in both the number and size of EEF in the presence of a blood infection (Fig. 2a-c) suggested that some nutrient or growth factor might be limiting liver-stage development. Previous reports have linked iron availability and Plasmodium infection of both RBCs 11 and hepatocytes [12] [13] [14] . Hamp, the gene encoding the iron regulatory hormone hepcidin, is significantly overexpressed in the livers of mice with ongoing blood-stage infection (2.2-fold increase in mice after primary infection by microarray analysis, P < 0.05, Supplementary Table 1) . We confirmed by qRT-PCR an average fivefold increase in Hamp expression in mice with an ongoing blood-stage infection (P < 0.01; Fig. 3a) , consistent with previous findings of increased hepcidin mRNA and peptide in human blood-stage infection 15, 16 . Of note, hepcidin mRNA levels fully correlated with parasitemia and, above a certain threshold (3.3-fold hepcidin increase for 0.15% parasitemia), inversely correlated with P. berghei liver infection (P < 0.01; Fig. 3a) . The increase in hepcidin mRNA expression depended on blood-stage parasitemia, as it reverted to normal levels after chloroquine treatment of infected mice (Fig. 3b) or after resolution of P. c. chabaudi AS infection (Supplementary Fig. 5 ), correlating with regained permissiveness to liver-stage re-infection ( Fig. 1i,j) . Hepcidin regulates iron homeostasis and distribution by targeting the iron exporter ferroportin for degradation, thereby preventing release of recycled RBC iron and dietary iron to serum from ferroportinexpressing macrophages and enterocytes, respectively 5, 17 . We found that increased Hamp expression during blood-stage infection was associated with iron redistribution manifesting as increased levels of ferritin within liver macrophages (Fig. 3c) , increased iron in the spleen and reduced iron in hepatocytes (Fig. 3d) . IL-6 and bone-morphogenetic proteins (BMPs) are known hepcidin agonists 18, 19 . Blood-stage infection increased expression in the liver of the gene encoding inhibitor of DNA binding-1 (Supplementary Fig. 5 ), a known BMP target gene 20 , and Hamp upregulation in primary hepatocytes by sera of blood-stage infected mice was inhibited by dorsomorphin (Fig. 3e) , a BMP signaling antagonist 21 . Induction was also partially neutralized by IL-6-specific antibodies (Fig. 3e) , suggesting that BMP and IL-6 pathways may work together to induce hepcidin during a blood-stage infection.
Previous microarray analysis showed that ferroportin expression was significantly reduced in Plasmodium-infected hepatoma cells (47.0 ± 0.2% reduction, P < 0.0001), and expression of the iron importer divalent metal transporter-1 was significantly increased (2.0 ± 0.2 fold increase, P < 0.0001) 22 . This suggests that iron acquisition and retention might be essential for complete Plasmodium development inside host cells. Consistent with this, reducing iron availability in liverderived cells with the iron chelators bathophenanthrolinedisulfonate and desferrioxamine led to marked and dose-dependent inhibition of Plasmodium EEF development (Fig. 3f-h and Supplementary Fig. 5 ), whereas iron supplementation using ferric ammonium citrate (FAC) dramatically increased development (Fig. 3g,h) . These effects were reproduced in mice infected with P. berghei sporozoites (Fig. 3h) .
Our data reveal that the abundance of iron, necessary for complete Plasmodium sporozoite development, significantly (P < 0.05, Fig. 3d ) reduced in hepatocytes during a malaria blood-stage infection, presumably due to increased hepcidin expression. Thus, elevated hepcidin alone without ongoing blood-stage infection should inhibit Plasmodium liver infection. Accordingly, administration of hepcidin peptide 17, 23, 24 before and after sporozoite infection significantly impaired liver infection (P < 0.05, Fig. 3i) . Additionally, two distinct hepcidin overexpression systems (Hampexpressing adenovirus-infected mice and HAMP-transgenic mice 25 , both causing a twofold higher Hamp expression in the liver compared to wildtype mice) showed that hepcidin significantly reduces liver-stage infection (P < 0.01 and P < 0.05, respectively, Fig. 3i ) to levels similar to those observed during blood-stage infection (Fig. 3a) . Together, these data are consistent with an ongoing blood-stage infection stimulating hepcidin expression and consequently redistributing iron away from hepatocytes where it is required for successful Plasmodium EEF development (Fig. 3j) .
We next asked what implications our observations in mice might have for human malaria, assuming the same phenomenon operates. Epidemiological studies from highly endemic areas consistently show that the incidence of infection first increases with age in young children before declining as a result of acquired immunity (for example, see refs. 4, 26) . In parallel, the complexity of infection, that is, the average number of parasite clones per individual, also increases as hosts get older 4, [26] [27] [28] , so that older children frequently harbor asymptomatic infections consisting of multiple parasite genotypes 2 , whereas superinfection is rarely encountered in infants, even though these individuals are less immune. To investigate if a threshold-density dependent inhibitory effect, such as we report here, could account for these counterintuitive observations, we devised a simple agent-based model. We simulated infection histories in a number of individuals, following them over time while recording the average annual infection rates and number of co-infecting clones (see Supplementary Methods). According to epidemiological observations, the model assumes that the average parasite density per infection decreases with age 4, 27, 29 . The probability of an infectious bite initiating a new infection then depends on current blood-stage parasitemia together with the host's infection history. Under these minimal assumptions, the model correctly predicts (Fig. 4) an initial increase in infection rates, which subsequently declines as individuals acquire immune protection through repeated exposure (Fig. 4a,c) . We also observe an increase in the multiplicity of infection in older individuals as a consequence of higher infection risk and reduced inhibitory effect of suppression of secondary liver-stage infection (Fig. 4b,d) . We tested the model under various assumptions regarding the relationship between an ongoing blood-stage infection and the probability of superinfection and found that no other inhibitory effect, such as premunition or density dependence, could explain the observed data (Fig. 4a,b) . The predictions of the model were also invariant to assumptions regarding age-dependent parasite clearance rates and maternal protection (Supplementary Fig. 6 ). This means that threshold-density-dependent inhibition of new liver-stage infections alone can explain the changes in infection risk and complexity of infections in young individuals observed in the field. Crucially, however, our results show that this effect is strongly dependent on the transmission intensity, defined by the entomological inoculation rate (EIR), and most prominently observed under moderate to high transmission settings (Fig. 4c,d) . A previous attempt to explain these epidemiological observations 30 relied on the biting preference of mosquitoes toward older individuals. Our findings provide an alternative (or synergistic) mechanism underlying the differences in age-dependent risk of infection within the endemicity spectrum (Fig. 4f) .
Host-pathogen-environment interactions can be extremely complex. For example, to maximize survival, some bacteria employ quorum sensing 31 , paracrine signaling 32 and even hormonal communication with their host (called interkingdom signaling 33 ). Similarly, the intricacy of the Plasmodium life cycle and its infection dynamics within host populations probably reflect behaviors that have been selected for during Infected individuals thus become susceptible to further infections only once parasite densities fall below a critical threshold, reducing both the overall infection rate and probability of multiclonal infections in young children. As they grow older, however, their typical blood parasitemia levels drop, and they more rapidly lose the protective effect against superinfection. As a result, successive infections become more frequent and more likely to occur before an ongoing blood-stage infection is cleared, which then causes the observed increase in multiplicity of infection.
coevolution. Our results suggest a previously unsuspected aspect of this relationship, that blood-stage Plasmodium infections protect their erythrocyte niche from superinfection via the upregulation of a host hormone, hepcidin, which redistributes iron away from competitor liverstage infections. This interaction acts independently of and in addition to acquired immunity and could resolve features of malaria epidemiology that have hitherto required speculation (Fig. 4f) . It is possible that the mechanism we describe arose to maintain parasite density below lifethreatening levels in nonimmune individuals, benefiting both the host and the incumbent pathogen. The effect implies a balance of host iron levels, blood parasitemia and the hepcidin response. One might therefore expect that altering iron availability could disturb these interactions. Indeed, a clinical trial of iron supplementation in children under age five on Pemba Island, Tanzania, where malaria is highly endemic, showed a statistically significant increase in malaria infections and risk of death in those children receiving iron 34 . Similarly, the profound and poorly explained anemia that accompanies the disease may be partly due to the hepcidin response. Understanding how the life stages of Plasmodium interact with the nutritional and immunological states of hosts of various ages may benefit the current efforts to control malaria.
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